AV

Arthur A. Vandenbark

OU Oregon Health & Science University: 22 patents #1 of 725Top 1%
DA Department Of Veterans Affairs: 10 patents #4 of 615Top 1%
UA US Dept of Veterans Affairs: 5 patents #10 of 605Top 2%
UM University Of Maryland: 1 patents #209 of 857Top 25%
CO Cormetrics: 1 patents #13 of 45Top 30%
📍 Portland, OR: #707 of 9,213 inventorsTop 8%
🗺 Oregon: #1,562 of 28,073 inventorsTop 6%
Overall (All Time): #151,801 of 4,157,543Top 4%
26
Patents All Time

Issued Patents All Time

Showing 1–25 of 26 patents

Patent #TitleCo-InventorsDate
11945855 Recombinant polypeptides comprising modified MHC class II DRa1 domains and methods of use Roberto Meza-Romero, Halina Offner 2024-04-02
10689446 Recombinant CD74 polypeptides Roberto Meza-Romero, Gil Benedek 2020-06-23
10525101 Methods of treating inflammatory or autoimmune disorders with compounds that bind macrophage migration inhibitory factor Gil Benedek, Roberto Meza-Romero 2020-01-07
10316075 Recombinant polypeptides comprising MHC class II α1 domains Roberto Meza-Romero, Gil Benedek, Gregory G. Burrows 2019-06-11
9926360 Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells Gregory G. Burrows 2018-03-27
9492536 Compositions and methods using recombinant MHC molecules for the treatment of stroke Halina Offner, Patricia D. Hurn, Gregory G. Burrows 2016-11-15
9359425 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction Gregory G. Burrows 2016-06-07
9260506 Treatment of retinal disorders with recombinant T cell receptor ligand (RTL) Grazyna Adamus 2016-02-16
9243051 Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells Gregory G. Burrows 2016-01-26
9050279 Compositions and methods using recombinant MHC molecules for the treatment of stroke Halina Offner, Patricia D. Hurn, Gregory G. Burrows 2015-06-09
8895018 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction Gregory G. Burrows 2014-11-25
8685404 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction Jennifer Loftis, Marilyn Huckans 2014-04-01
8491913 Compositions and methods using recombinant MHC molecules for the treatment of stroke Halina Offner, Gregory G. Burrows, Patricia D. Hurn 2013-07-23
8435507 Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer Richard B. Alexander, Elena N. Klyushnenkova, Jason Link 2013-05-07
8377447 Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells Gregory G. Burrows 2013-02-19
8053197 Methods for detecting and treating autoimmune disorders Halina Offner, Richard Bartholomew 2011-11-08
7732140 Method for direct electrical detection of molecules and molecule-molecule interactions Rajendra Solanki 2010-06-08
7462486 Methods of selecting T cell receptor V peptides for therapeutic use 2008-12-09
7265218 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells Gregory G. Burrows 2007-09-04
7214528 Device for direct electrical detection of molecules and molecule-molecule interactions Rajendra Solanki 2007-05-08
6815171 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells Gregory G. Burrows 2004-11-09
6566082 T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions Andrew D. Weinberg 2003-05-20
6270772 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells Gregory G. Burrows 2001-08-07
5776459 TCR V beta 5 peptides 1998-07-07
5759546 Treatment of CD4 T-cell mediated conditions Andrew D. Weinberg 1998-06-02